Search the Newsreel

Delcath Systems, Inc. Revenue Breakdown – LS:A2PT5P

Delcath Systems, Inc. generated €72.57 million in revenue last year, with its top-performing segment, Hepzato Kit, contributing €67.12 million, a significant increase from €31.20 million in the prior year. All of this top segment's revenue came from the United States. The article provides a …

Bloom Energy Tumbles 13%, FuelCell Energy Drops 9%, Plug Power Slips 4% in Fuel-Cell Selloff

Quick Read Bloom Energy and FuelCell Energy fell 13% and 9% Friday but remain up 119% and 192% year to date after vertical AI-power rallies. The HYDR hydrogen ETF's 5% drop confirms sector-wide selling, while Bloom Energy's Oracle warrant partnership anchors the AI data …

Enterprise value to EBITDA forward of FuelCell Energy, Inc. – HAM:FEY

This article provides financial information for FuelCell Energy, Inc. (HAM:FEY), specifically focusing on its enterprise value to EBITDA forward ratio. It notes that the market for this particular stock is closed with no recent trades. The content primarily serves as a financial data point …

Celcuity Inc. (CELC) Investor Outlook: Analyzing an 85% Upside Potential in the Biotech Sector

Celcuity Inc. (CELC), a clinical-stage biotech company with a $4.31 billion market cap, is drawing investor attention due to an 85% potential upside based on analyst ratings. The company is developing Gedatolisib for advanced breast and prostate cancer, backed by a licensing agreement with …

233,385 Shares in Melco Resorts & Entertainment Limited $MLCO Bought by Capula Management Ltd

Capula Management Ltd has acquired a new position of 233,385 shares in Melco Resorts & Entertainment Limited (NASDAQ:MLCO), valued at approximately $1.33 million, representing about 0.06% of the company's stock. Other institutional investors have also adjusted their holdings in MLCO. The company's stock is …

Press Release: Delcath Systems to Host Second Quarter 2026 Earnings Call

Delcath Systems (NASDAQ: DCTH) announced it will host an earnings call on August 8, 2026, at 8:30 AM ET to discuss its second-quarter 2026 financial results. The call will follow the release of the results after market close on August 7, 2026. Interested parties …

Delcath Systems sets Aug. 6 briefing on second-quarter results

Delcath Systems, Inc. (Nasdaq: DCTH) announced it will host a conference call on August 6, 2026, at 8:30 AM Eastern Time to discuss its second-quarter 2026 financial results. The company specializes in interventional oncology, offering the HEPZATO KIT and CHEMOSAT systems for treating primary …

Understanding Momentum Shifts in (DCTH)

This article analyzes Delcath Systems Inc. (DCTH), highlighting a weak near-term sentiment that could lead to bearish positioning with a significant risk-reward short setup. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods. The …

FuelCell Energy (FCEL) Stock May Already Trade At A Premium As Equity Raise Lands

FuelCell Energy (FCEL) stock has seen a significant 281.5% return over the past year, but current valuations suggest it may be trading at a premium. The article highlights that the stock screens as overvalued based on traditional metrics and its Price/Sales ratio compared to …

Price to sales forward of Celcuity Inc. – NASDAQ:CELC

This article provides "Price to sales forward" information for Celcuity Inc. (NASDAQ: CELC), a company in the medical specialties sector. The content appears to be a financial data snippet from TradingView, indicating the stock market, sector, and financial metrics available. It is a very …

Celcuity faces securities fraud probe after FDA delays breast cancer drug launch, shares drop 17.6%.

Pomerantz LLP is investigating Celcuity Inc. for potential securities fraud. This investigation follows the company's announcement of a delayed commercial launch for its FDA-approved breast cancer drug, Revtorpyk, which caused a 17.6% drop in Celcuity's stock price on July 15, 2026. The probe will …

Earnings Preview: Melco Resorts (MLCO) Q2 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on lower revenues when Melco Resorts (MLCO) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term …

Melco Resorts & Entertainment (MLCO) Projected to Announce Quarterly Earnings on Thursday

Melco Resorts & Entertainment (MLCO) is expected to announce its Q2 2026 earnings before market open on Thursday, July 30th, with analysts projecting earnings of $0.06 per share and revenue of $1.2634 billion. The company's stock currently trades at $5.47, with institutional investors recently …

FuelCell Energy (FCEL) Stock Could Trade At A Premium On Fuel Cell Deal

FuelCell Energy (FCEL) stock has seen a significant 277.7% return over the past year, yet its current valuation, particularly its P/S ratio of 10.3x compared to an industry average of 2.9x, indicates it may be overvalued. The company's recent collaboration with Siemens and a …

With FDA approval, Celcuity sees big future for its new breast cancer drug

Minnesota-based biotech firm Celcuity received FDA approval for its new breast cancer drug, Revtorpyk, for a limited patient population. CEO Brian Sullivan believes the drug will become a "blockbuster" and a new standard of care, targeting a $6 billion market for HR+/HER2- advanced breast …

FuelCell Energy (NASDAQ: FCEL) details resale of 12M warrant shares by FIT

FuelCell Energy (NASDAQ: FCEL) has filed to register for resale up to 12 million shares of common stock, which are issuable upon the exercise of warrants held by FIT Energy USA LP. These warrants are divided into three tranches, each for 4 million shares, …

Siemens and FuelCell Energy Collaborate to Explore Scalable Fuel Cell Power Solutions

Siemens and FuelCell Energy have announced a collaboration to accelerate the growth of fuel cell-based power generation. This partnership will focus on aligning electrical design and supply with fuel cell technologies to support the deployment of distributed energy systems. The goal is to deliver …

FuelCell Energy files prospectus supplement; Latham & Watkins legal opinion attached

FuelCell Energy (FCEL) has filed a prospectus supplement to its Form S-3, including a legal opinion from Latham & Watkins LLP regarding the legality of issuance. This filing confirms compliance for future securities offerings. The information is based on an SEC 8-K filing from …

CELCUITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Celcuity Inc. on Behalf of Celcuity Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Celcuity (CELC) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Celcuity and would like to discuss your legal rights, contact Bragar Eagel …

CELC Stock Clocks Best Day In About 2 Months On First FDA Approval For Cancer Drug

Celcuity Inc. (CELC) shares surged 7% after the FDA approved its drug gedatolisib, in combination with fulvestrant, for advanced hormone receptor-positive, HER2-negative breast cancer. This approval marks Celcuity's transition from a development-stage company to one with a commercial product, and the company intends to …

Melco Resorts stock trades steady as Macau recovery supports revenue growth

Melco Resorts' stock performance is closely tied to the Macau gaming recovery, with recent quarterly revenues showing double-digit growth due to increased visitation. While the company's revenue trends are improving, net income has fluctuated, influenced by various gaming segments and operating expenses. Investors are …

Celcuity (CELC) Is Down 17.4% After FDA Clears First-in-Class REVTORPYK Combo for HR+ Breast Cancer

Celcuity (CELC) saw a 17.4% stock drop despite FDA approval for its first-in-class drug REVTORPYK for HR-positive, HER2-negative breast cancer. The approval, based on strong progression-free survival data from the VIKTORIA-1 trial, shifts the company's focus to market uptake and managing increased debt from …

Why CELC Stock Declined 15% in a Week Despite a Major FDA Win

Despite securing FDA approval for its first marketed product, Revtorpyk, Celcuity (CELC) stock declined 15% in a week. The decline is attributed to investor disappointment over the delayed commercial launch of Revtorpyk, now set for the late third quarter of 2026, which impacts near-term …

FCEL vs. GEV: Which AI-Powered Energy Stock Is a Better Buy?

This article compares FuelCell Energy (FCEL) and GE Vernova (GEV) as AI-powered energy stocks, highlighting their differing approaches to capitalizing on increased electricity demand from data centers and grid modernization. While FCEL focuses on distributed fuel-cell systems for on-site power, GEV offers a broader …

Kirby McInerney LLP investigates Celcuity for potential securities fraud after FDA approval delays impact stock price.

Kirby McInerney LLP is investigating Celcuity Inc. for potential securities fraud. This probe follows a significant 17.6% drop in Celcuity's stock price after the company announced a delayed commercial launch for its FDA-approved breast cancer therapy, Revtorpyk, to late Q3 2026, which was later …

CELC INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Celcuity Inc. (“Celcuity” or the “Company”) (Nasdaq: CELC). The investigation concerns whether the Company and/or members of its senior management may have violated federal …

Monday 7/20 Insider Buying Report: ELV, FCEL

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Elevance Health, a filing with the …

FuelCell Energy (FCEL) director purchases 26,343 shares at $18.7893

FuelCell Energy Inc. director Homer John Livingston III purchased 26,343 shares of Common Stock on July 16, 2026, for a weighted average price of $18.7893 per share. This transaction was an open market or private purchase and was not made under a Rule 10b5-1 …

FCEL Stock Surges As Data Center Deals Transform Outlook

FuelCell Energy Inc. (FCEL) stock surged by 7.7% following a significant long-term deal with Fit Energy USA to supply up to 380 MW of clean baseload power for data centers, starting as early as 2026. This catalyzing event led to multiple analyst upgrades from …

FuelCell Energy Inc. stock rises Monday, outperforms market

FuelCell Energy Inc. (FCEL) stock rose 7.27% to $19.84 on Monday, outperforming the broader market. This marked the stock's second consecutive day of gains, despite a generally negative trading session where the NASDAQ Composite Index fell 0.05% and the Dow Jones Industrial Average fell …

FuelCell Energy Rallies 6% While Bloom Energy Slides 6%, Splitting the Fuel-Cell Trade

FuelCell Energy (NASDAQ:FCEL) surged 6% on Monday due to optimism around AI data center power deals, while Bloom Energy (NYSE:BE) stock dropped 6% after TD Cowen reiterated a Hold rating and flagged potential project delays and its high valuation. This split indicates a divergence …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Celcuity Inc. (CELC) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Celcuity Inc. (NASDAQ:CELC) following a significant drop in its stock price. The investigation stems from Celcuity's announcement of FDA approval for its breast cancer therapy, Revtorpyk, with an anticipated commercial launch in late Q3 …

Melco Resorts & Entertainment (MLCO) Q4 2024 earnings summary

Melco Resorts & Entertainment (MLCO) reported a strong Q4 2024, with operating revenues increasing by 8.9% year-over-year to $1.19 billion, and full-year revenues reaching $4.64 billion. The company significantly narrowed its net loss and saw market share in Macau exceed pre-pandemic levels. Looking ahead, …

Delcath Systems announces inducement grants

Delcath Systems, Inc. announced the granting of equity awards consisting of 17,000 Restricted Stock Units (RSUs) to four new employees who joined in May or June 2026. These inducement grants were made under the company's 2023 Inducement Plan on July 1, 2026. The RSUs …

Steelcast stock trades up to 305.00 as Steelcase promotes home office design themes

Celcuity (CELC) Stock May Be Overvalued After REVTORPYK Approval

Despite a significant 7x return over three years and the FDA approval of REVTORPYK, Celcuity (CELC) stock appears overvalued, primarily due to its high price-to-book (P/B) ratio of 80.5x, far exceeding industry averages. The mixed valuation score suggests that current expectations already discount substantial …